Plate readers for bioproduction

Multimode microplate readers that measure absorbance, fluorescence, luminescence and time-resolved FRET across 96-, 384- and 1536-well plates — the shared detection backbone behind ELISA, cell viability, reporter-gene and high-throughput screening assays across biopharma R&D and QC.

analytics-pat Low 7 min
verified 11 Aug 2026 valid until confidence HIGH 25 sources
EC: US FDA 21 CFR Part 11 + USP <1225> for microplate-based assay method validation fda ema nmpa

01Overview and value chain#

Markers EC: US FDA 21 CFR Part 11 + USP <1225> for microplate-based assay method validation | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)

Plate readers measure optical signal — absorbance, fluorescence intensity, luminescence, or time-resolved and polarization variants of fluorescence — across every well of a microplate, converting a biochemical or cell-based assay into a quantitative dataset in a single scan. A single multimode instrument typically covers all these detection modes on one optical bench, letting the same reader serve an ELISA absorbance endpoint, a cell-viability luminescence assay, and a reporter-gene fluorescence screen without switching hardware. Detection architecture splits into two main approaches: filter-based systems use interchangeable optical filters tuned to specific wavelengths, offering high sensitivity for a fixed assay menu, while monochromator-based systems use continuously tunable gratings that trade some sensitivity for the flexibility to read any wavelength without a filter change — a meaningful advantage in a lab running varied assay protocols. Plate readers sit in nearly every step of a biopharma discovery-to-QC pipeline: high- throughput screening in early discovery, cell-based potency and reporter-gene assays in development, and the absorbance endpoint of a routine ELISA in QC — making the instrument one of the most broadly deployed pieces of analytical hardware in the industry.

The key directions of plate reading for bioproduction are:

  1. Monochromator-based multimode detection (Monochromator Detection): continuously tunable optical gratings read any wavelength without a filter change, the flexible default for labs running varied assay protocols.
  2. Filter-based high-sensitivity detection (Filter-Based Detection): interchangeable optical filters tuned to fixed wavelengths deliver higher sensitivity for a defined, repeated assay menu than a monochromator system.
  3. High-throughput 1536-well screening (HTS Plate Reading): fast-scanning multimode readers built for high-density plate formats, the workhorse for early-discovery high-throughput screening campaigns.
  4. Time-resolved fluorescence and FRET detection (TR-FRET): pulsed excitation with delayed-signal reading suppresses short-lived background fluorescence, improving signal-to-noise for homogeneous binding and cell-based assays.

Sectoral value chain#

[Microplate: 96/384/1536-well] ──> [Optical excitation/light source] ──> [Signal detection: absorbance/fluorescence/luminescence] ──> [Well-by-well raw signal]
                                                                  │
                                                          (curve fitting/normalization)
                                                                  │
                                                                  ▼
[Assay result: EC50, titer, concentration] <─── [Software: data reduction, plate-map assignment]
Fig. 1— Sectoral value chain

Value chain levels#

LevelDescriptionKey inputs/outputs
Plate loadingThe microplate, prepared with sample and assay reagents, is loaded manually or via an automated plate stacker/robotic arm.In: prepared assay microplate. Out: loaded plate positioned for reading.
Optical excitationA light source (xenon flash lamp or LED, depending on detection mode) illuminates or excites each well in sequence or in parallel.In: loaded plate. Out: excited/illuminated wells ready for signal capture.
Signal detectionA photomultiplier tube or CCD/CMOS sensor captures absorbance, fluorescence, or luminescence signal from each well.In: excited/illuminated wells. Out: raw well-by-well optical signal.
Software: data reductionInstrument software applies background subtraction, blank correction and plate-map assignment to raw signal.In: raw well signal. Out: normalized, plate-map-assigned data.
Curve fitting and calculationSoftware fits a standard curve or dose-response model to derive quantitative results such as concentration or EC50.In: normalized data. Out: calculated assay results (concentration, EC50, titer).
ReportingResults export to a LIMS, ELN or statistical-analysis package for downstream use.In: calculated results. Out: formatted report or data export.
Table 1— Value chain levels

Cross-cutting technologies of the sector:

  • Integrated plate-handling robotics: stacker and robotic-arm attachments turn a standalone reader into an unattended high-throughput screening node within a larger automated workflow.
  • Dual/quad monochromator optics: independent excitation and emission monochromators reduce stray-light interference versus a single shared grating, improving assay sensitivity for low-signal fluorescence work.
  • Software-defined detection-mode switching: modern instruments switch between absorbance, fluorescence, luminescence and TR-FRET modes purely in software, without physical reconfiguration between assay runs.

02US#

The US hosts three of the category’s largest instrument makers, spanning early-discovery high-throughput screening through routine ELISA and cell-based assay work.

high-throughput screening platforms, multimode assay flexibility, discovery-to-QC instrument continuity#

  • Agilent (BioTek): the Synergy family — including the Synergy H1, Synergy 2 and Synergy Neo2 hybrid readers — spans a wide sensitivity and throughput range under the BioTek brand now integrated into Agilent’s life-science instrument portfolio.
  • Molecular Devices: the SpectraMax M-series and SpectraMax Mini multimode readers measure UV/visible absorbance, fluorescence and luminescence for applications spanning ELISA, DNA/protein quantitation, cell viability and gene-expression assays.
  • Revvity: the EnVision 2105 multimode plate reader emphasizes speed, high throughput and sensitivity across all major detection technologies, with new discovery-platform innovations showcased at SLAS2026.

03CN#

No China-headquartered plate-reader manufacturer cleared this screening round with confirmed, on-domain evidence tied to a specific company; demand is driven by China’s expanding biopharma discovery and QC-testing base, currently served largely through the global vendors’ regional distribution and applications-support networks.

import-dependent instrumentation, domestic biopharma discovery/QC demand, distributor-served market#

  • Global vendor distribution: Agilent, Molecular Devices, Tecan, Revvity and BMG Labtech each maintain China sales and applications-support organizations serving domestic biopharma discovery and QC laboratories.
  • Domestic biopharma build-out: China’s growing high-throughput screening and QC testing base is the main demand driver for plate readers, without a confirmed domestic instrument originator identified in this screen — industry-report and marketplace content confirmed a general domestic market for multifunction plate readers, but no specific company name cleared verification.

04EU#

Switzerland and Germany both contribute established multimode plate-reader platforms, each with a distinct optical-configuration approach.

fully configurable multimode platforms, high-performance monochromator optics, flexible detection-mode assay menus#

  • Tecan (Switzerland): the Spark multimode microplate reader is a fully configurable platform, letting labs personalize the detection modes and hardware configuration on a single instrument chassis.
  • BMG LABTECH (Germany): the CLARIOstar Plus high-performance monochromator multimode reader uses advanced linear-variable-filter (LVF) monochromator optics alongside highly sensitive filters for flexible, high-sensitivity multimode detection.

05Leading companies and research institutes#

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Agilent (BioTek)🇺🇸 USASynergy H1, Synergy 2, Synergy Neo2Hybrid multimode detection across a wide sensitivity/throughput rangeCommercial, public (NYSE: A)
Molecular Devices🇺🇸 USASpectraMax M-series, SpectraMax MiniAbsorbance/fluorescence/luminescence across ELISA, viability and gene-expression assays (Danaher)Commercial
Tecan🇨🇭 SwitzerlandSparkFully configurable, personalized multimode detection platformCommercial, public (SIX:TECN)
Revvity🇺🇸 USAEnVision 2105High-speed, high-throughput multimode detectionCommercial, public (NYSE:RVTY)
BMG LABTECH🇩🇪 GermanyCLARIOstar PlusLVF monochromator optics; high-sensitivity flexible detectionCommercial
Table 2— Leading companies and research institutes

06Tech stack and innovations#

The stack layers light-source excitation, optical filtering or monochromation, and photodetector-based signal capture on a common data-reduction software backbone, with the choice of platform driven by assay-menu flexibility versus fixed-assay sensitivity needs.

  1. Monochromator-based optics:
    • Continuously tunable diffraction gratings or linear-variable filters select any excitation or emission wavelength in software, without physically swapping optical filters between assays.
    • Trades a modest sensitivity penalty versus dedicated filters for the flexibility to run an unplanned or newly developed assay without new hardware.
  2. Filter-based fixed-wavelength optics:
    • Interchangeable narrow-bandpass filters, each tuned to a specific assay’s excitation/emission wavelengths, maximize signal throughput and sensitivity for a defined, repeated assay menu.
    • Preferred where a lab runs the same handful of validated assays at high volume and values maximum sensitivity over reconfiguration flexibility.
  3. Robotic plate-handling integration:
    • Stacker or robotic-arm attachments feed plates into the reader unattended, turning a standalone instrument into a node within a larger automated high-throughput screening or QC workflow.
    • Software-driven scheduling coordinates plate movement with detection-mode switching for multi-assay unattended runs.

07Value chains and production pipelines#

Industrial pipeline of a multimode plate-reader assay run (USP <1225> / 21 CFR Part 11)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Plate loading            │ ───> │ 2. Optical excitation        │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Data reduction           │ <─── │ 3. Signal detection          │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Curve fitting            │ ───> │ 6. Result report/export     │
└───────────────────────────┘      └───────────────────────────┘
Fig. 2— Industrial pipeline of a multimode plate-reader assay run (USP <1225> / 21 CFR Part 11)

Stage 1: Plate loading

A microplate, already prepared with sample and assay-specific reagents, is loaded onto the reader manually or via an automated plate stacker or robotic-arm attachment.

Stage 2: Optical excitation

Depending on the assay’s detection mode, a xenon flash lamp or LED source illuminates each well for absorbance measurement or excites fluorophores for fluorescence-based detection.

Stage 3: Signal detection

A photomultiplier tube or CCD/CMOS sensor captures the resulting absorbance, fluorescence, or luminescence signal from each well, scanning the plate well-by-well or in parallel depending on instrument architecture.

Stage 4: Data reduction

Instrument software applies background subtraction, blank correction and plate-map assignment, converting raw per-well signal into normalized, assay-ready data.

Stage 5: Curve fitting

Software fits a standard curve, dose-response model or other statistical model to the normalized data, deriving quantitative results such as concentration, titer or EC50.

Stage 6: Result report or export

Calculated results are formatted into a report or exported to a LIMS, ELN or statistical-analysis package, with a 21 CFR Part 11-compliant audit trail for GxP environments.


SupplierPriceLead timeCertificatesRiskConfidence
Molecular Devices$35K6 wkCommercialLowHIGH
Tecancustomon requestSIX:TECN CommercialLowHIGH
Revvitycustomon requestNYSE:RVTY CommercialLowHIGH
BMG LABTECH$45K8 wkCommercialLowHIGH
AI Recommendation

Agilent’s BioTek Synergy line is the safest default for most labs — it spans a wide sensitivity/throughput range under one brand, and the hybrid architecture means you’re not locked into filter-only or monochromator-only detection. Molecular Devices’ SpectraMax is worth a look specifically if your assay menu is already standardized on their software ecosystem, since switching platforms means re-validating methods. Tecan’s Spark is the pick if configurability matters more than out-of-box simplicity — it’s built to be personalized down to the hardware level rather than sold as a fixed configuration. BMG LABTECH’s CLARIOstar Plus stands out for its monochromator optics specifically — worth the look if you need flexibility across a genuinely varied assay menu rather than a handful of validated protocols. Revvity’s EnVision is the throughput-first choice if you’re running true high-throughput screening campaigns rather than routine QC volumes.

Key directions: monochromator-based multimode detection, filter-based high-sensitivity detection, high-throughput 1536-well screening, and time-resolved fluorescence/FRET.

Regulatory: microplate-based assay methods used for GxP release testing need to satisfy USP <1225> method-validation requirements, with 21 CFR Part 11-compliant software audit trails on the data-reduction side.

Companies not in table: industry-report and marketplace content confirmed a general domestic Chinese market for multifunction plate readers, but no specific company name cleared verification against its own domain this round — so no China-headquartered vendor is tabled here.

Sources

25 sources · 5 organisations · retrieved 11 Aug 2026 · confidence HIGH
  1. Agilent · us
  2. Genetix · US
  3. Tecan · CH
  4. Revvity · US
  5. BMG Labtech CLARIOstar · DE
Cite this dossier
Bioecon (2026). Plate readers for bioproduction. Bioecon — independent bioeconomy intelligence platform. verified 11 August 2026. https://en.bioecon.ru/technology/plate-readers-bioproduction/
Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.